Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT00433238
Other study ID # WCMSH
Secondary ID
Status Not yet recruiting
Phase Phase 1
First received February 7, 2007
Last updated February 7, 2007
Start date March 2007

Study information

Verified date February 2007
Source Mount Sinai Hospital, Canada
Contact K.C. Chan
Phone 416-291-3883
Email kcchan@mtsinai.on.ca
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The study is designed to answer the following research questions:

1. Evaluate the acceptability of mental health screening and of the instruments used in a sample of community living Chinese seniors;

2. Determine rates of mental health service utilization in individuals identified at screening as having psychological disturbance;

3. Determine if identifying mental illness and informing participants of screening results and with treatment alternatives alters help-seeking pathways.

The study hypotheses are:

1. This community sample of Chinese seniors will show a higher prevalence of psychological disturbance than their counterparts in the general population;

2. Emotional well-being will be positively correlated with individuals' physical health and social support network.


Description:

A convenience sample will be drawn from 6 Congregate Dining (CD) groups in the Chinese community. There are six groups of CD programs run by Yee Hong Centre for Geriatric Care run at different locations in the Greater Toronto Area. The screening will be offered on site at regular CD meetings to participants who have given informed, written consent. All participants will attend a private post-screening interview. Those who score above the threshold for depression and/or cognitive impairment, and who have not previously been diagnosed or treated for these conditions, will be randomly assigned to one of two groups: an intervention group and a usual care group. Participants in the intervention group will receive their screening results at the post-screening interviews and will also be provided with suggestions for possible follow-up. They will be given the option of receiving further psychiatric assessment at the Wellness Centre, or seeking care with their family physician and assisted to obtain further care, if desired. Participants in the intervention group will attend an appointment 3 months after receiving screening results and follow-up options during which the rate of help seeking, rate of confirmed psychiatric diagnoses and types of intervention received will be determined. Participants in the usual care group will not be given screening results at the post-screening interview but will instead attend an appointment 3 months post screening to receive their results and information about follow-up options.

The results of this research will: demonstrate whether community living Chinese elders are at greater risk of psychiatric disorders and demonstrate the need for screening in older Chinese adults living in the community; aid in the development of systematic and targeted community-based screening and outreach to at-risk members of the target population; and help determine if identification of mental health issues and education about treatment resources has any effect on help-seeking for those conditions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 55 Years to 85 Years
Eligibility Inclusion Criteria:

- capable of providing informed consent

- informed consent

Exclusion Criteria:

- Individuals who are unable to fully understand the nature of the study, its possible risks and benefits and the consequences of providing or withholding consent, and who are, therefore, not capable of providing informed consent will be excluded from the study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Screening


Intervention

Behavioral:
Participants will be screened for depression and cognitive impairment, then receive screening results.


Locations

Country Name City State
Canada Wellness Centre Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Mount Sinai Hospital, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of help seeking in intervention group
Primary Rate of confirmed psychiatric diagnoses in intervention group
Primary Type of intervention received
See also
  Status Clinical Trial Phase
Recruiting NCT05537558 - Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
Terminated NCT02192099 - Open Label Extension for GLYX13-C-202, NCT01684163 Phase 2
Completed NCT03142919 - Lipopolysaccharide (LPS) Challenge in Depression Phase 2
Recruiting NCT05547035 - Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders N/A
Terminated NCT02940769 - Neurobiological Effects of Light on MDD N/A
Recruiting NCT05892744 - Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression Phase 4
Recruiting NCT05537584 - SMART Trial to Predict Anhedonia Response to Antidepressant Treatment Phase 4
Active, not recruiting NCT05061706 - Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Phase 3
Completed NCT04479852 - A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder Phase 2
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Recruiting NCT05527951 - Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study N/A
Completed NCT03511599 - Cycloserine rTMS Plasticity Augmentation in Depression Phase 1
Recruiting NCT04392947 - Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation N/A
Recruiting NCT05895747 - 5-HTP and Creatine for Depression R33 Phase Phase 2
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Recruiting NCT05813093 - Interleaved TMS-fMRI in Ultra-treatment Resistant Depression N/A
Recruiting NCT05135897 - The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
Enrolling by invitation NCT04509102 - Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder Early Phase 1
Recruiting NCT06145594 - EMA-Guided Maintenance TMS for Depression N/A
Recruiting NCT06026917 - Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Phase 4